Hydroxychloroquine does not usually make your skin more sensitive to the sun, and most people taking it can spend time outdoors without unusual risk of sunburn. A phototesting study of rheumatoid arthritis patients found that UV thresholds did not change while on the drug, concluding that photosensitivity during hydroxychloroquine use is uncommon. Yet the question persists, in part because many of the conditions hydroxychloroquine treats are themselves triggered or worsened by sun exposure, and because rare but real skin reactions do occur.
What Phototesting Studies Actually Found
The most direct evidence comes from a study that phototested 25 rheumatoid arthritis patients both while they were taking chloroquine or hydroxychloroquine and while they were off it. The researchers measured each patient’s threshold for burning under both UVA and UVB light. Neither threshold changed on the medication. Even provocation with high doses of UVA and UVB produced the same reaction whether or not the patients were on the drug. The study’s conclusion was blunt: photosensitivity during hydroxychloroquine treatment is uncommon, and there is no need to stop the drug because of sun exposure.1PubMed. Sensitivity to UV light during treatment with chloroquine in rheumatoid arthritis
This is reassuring, but it is worth noting the study was small. Twenty-five patients is enough to detect a consistent pharmacological photosensitizing effect, the kind you see with drugs like doxycycline or hydrochlorothiazide, where the majority of users become noticeably more sun-reactive. It is not enough to rule out rare, idiosyncratic reactions in a small minority of people. That distinction matters.
Why People Assume Hydroxychloroquine and Sunlight Don’t Mix
Much of the confusion stems from who takes the drug. Hydroxychloroquine is one of the most commonly prescribed medications for systemic lupus erythematosus, and lupus is famously photosensitive. Ultraviolet light can trigger or worsen lupus flares, skin rashes, and joint pain in many patients regardless of what medications they take. When someone with lupus gets a rash after a sunny afternoon, it is easy to blame the pill rather than the disease. In reality, hydroxychloroquine is often prescribed specifically because it helps reduce the frequency of those UV-triggered flares.
Rheumatoid arthritis, the other major condition treated with hydroxychloroquine, is not classically photosensitive in the same way. The phototesting study mentioned above used RA patients in part because they provided a cleaner test: you could isolate the drug’s effect without the confounding variable of a UV-reactive disease.
There is also a labeling effect at work. Prescription leaflets and pharmacy printouts for hydroxychloroquine frequently include “photosensitivity” among possible side effects. Pharmacists reasonably flag it. But the fact that a reaction has been reported does not mean it is common. Drug information sheets list any reaction that has appeared in case reports or post-marketing surveillance, even when the overall incidence is very low.
Rare Phototoxic Reactions Do Happen
Uncommon does not mean impossible. Case reports have documented phototoxic reactions in patients taking hydroxychloroquine or the closely related drug leflunomide for connective tissue diseases. These reactions included redness in sun-exposed areas, sometimes resembling a severe sunburn, along with other dermatological changes like annular erythema and mucocutaneous hyperpigmentation.2PubMed Central. Cutaneous Adverse Effects of Hydroxychloroquine and Leflunomide in Connective Tissue Diseases: A Report of Three Cases and a Literature Review
A phototoxic reaction is different from ordinary sunburn. It happens when a drug absorbs UV energy and releases it in a way that damages skin cells directly. The result can look like an exaggerated sunburn, but confined to areas that were exposed to light. If you notice that your skin burns more easily or develops unusual redness, blistering, or discoloration in sun-exposed spots after starting hydroxychloroquine, it is worth bringing up with your prescriber. The reaction is not dangerous in most cases, but it is uncomfortable and can be mistaken for a lupus flare or an allergy.
The key practical point: the vast majority of people on hydroxychloroquine will never experience this. If you have been taking the drug for weeks or months and have not noticed any change in how your skin handles sunlight, you are almost certainly not among the rare reactors.
Hyperpigmentation From Long-Term Use
A separate skin concern with hydroxychloroquine is hyperpigmentation, where patches of skin darken over time. This is not a sunburn reaction, but sun exposure can make it more visible or worsen it. One reported case involved a 65-year-old woman who developed darkened patches across multiple areas of her body after three years of hydroxychloroquine use for rheumatoid arthritis. After stopping the drug, the discoloration gradually faded, though it took time.3Frontiers in Immunology. Hydroxychloroquine-induced hyperpigmentation of the skin and bull’s-eye maculopathy in rheumatic patients: a case report and literature review
Hydroxychloroquine-induced hyperpigmentation tends to appear in areas exposed to the sun, but it also shows up in areas that are not, which suggests the drug itself causes melanin or drug-metabolite deposits in the skin rather than simply amplifying a UV effect. The discoloration is typically blue-gray or brown, and it can affect the shins, forearms, face, and palate. It is more common in patients who have been on the drug for years rather than months.
This is worth distinguishing from photosensitivity. Photosensitivity means the sun causes more damage than it normally would. Hyperpigmentation means the drug is changing your skin’s color chemistry over time, and sun exposure can accentuate what is already happening. Protecting your skin from the sun may help slow hyperpigmentation, but it is not the root cause the way it would be with a truly photosensitizing drug.
The Half-Life Problem
One feature of hydroxychloroquine that makes any side effect harder to manage is its extraordinarily long half-life. The drug takes roughly 40 to 50 days to fall to half its concentration in your body after you stop taking it. That means if you do develop a skin reaction, whether photosensitivity or hyperpigmentation, it will not disappear quickly after discontinuation. The drug and its active breakdown products linger in tissue for months.4PubMed Central. Pharmacology of Chloroquine and Hydroxychloroquine
This long residence time has practical consequences for anyone managing a skin side effect. If you stop the drug because of a phototoxic reaction, you should not expect your skin’s normal sun tolerance to return for several months. This is unusual; most drug-related photosensitivity clears within days to a couple of weeks after stopping the medication. Hydroxychloroquine is an outlier because it accumulates in tissues, especially the skin, liver, and eyes, and leaves the body very slowly.
For the same reason, a phototoxic reaction might not appear immediately when you start the drug. It can take weeks for tissue levels to build to the point where the drug absorbs enough UV energy to cause noticeable skin damage. If you are watching for a reaction, the relevant window is not just the first few days after starting. Give it at least a few weeks of regular sun exposure before concluding you are in the clear.
Practical Sun Guidance for People on Hydroxychloroquine
Since most people taking hydroxychloroquine are not made photosensitive by it, the general advice is not dramatically different from what applies to everyone: use sunscreen, wear hats and protective clothing when you expect extended exposure, and be sensible about midday sun. You do not need to avoid the outdoors or live behind blackout curtains.
That said, a few situations call for extra caution:
- Lupus patients: If you take hydroxychloroquine for lupus, your sun precautions are driven by the disease, not the drug. UV light triggers flares in a large proportion of lupus patients. Broad-spectrum sunscreen with high SPF, sun-protective clothing, and limiting peak-hours exposure remain essential parts of managing lupus whether or not you are on hydroxychloroquine.
- New to the drug: During the first couple of months, pay attention to how your skin responds to sun exposure. If you notice burning at lower exposure levels than you are used to, or unusual redness or blistering confined to sun-exposed areas, contact your prescriber.
- Long-term users: If you have been on hydroxychloroquine for a year or more, watch for blue-gray or brown discoloration in sun-exposed skin. This is distinct from a sunburn and progresses slowly. Sun protection may slow it, but the primary fix is a conversation with your doctor about whether the benefit of the drug still outweighs this cosmetic side effect.
- Taking other photosensitizing drugs: If you are also on a known photosensitizer like a tetracycline antibiotic, a thiazide diuretic, or certain antifungals, the combined effect on your skin’s UV tolerance could be additive. In that case, be more careful about sun exposure even though hydroxychloroquine alone is unlikely to be a problem.
The Vitamin D Trade-Off
There is an ironic flip side to the sun-avoidance question. Many people on hydroxychloroquine, especially those with lupus, are told to stay out of the sun because of their underlying condition. But strict sun avoidance comes with its own cost: low vitamin D. A study of women with systemic lupus erythematosus found that a significant number had vitamin D levels below accepted thresholds, consistent with reduced sun exposure.5PubMed. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia
This is worth keeping in mind because low vitamin D can contribute to bone loss, fatigue, and immune dysregulation, all of which overlap with the symptoms hydroxychloroquine is meant to help. People who are strict about sun avoidance because of lupus should consider having their vitamin D levels checked periodically and supplementing if they are low. The point is not to abandon sun protection but to recognize that complete avoidance has metabolic costs, especially over years.
How Hydroxychloroquine Compares to Known Photosensitizers
To put the risk in context, some drugs are well-established photosensitizers where the effect is reproducible and dose-dependent. Doxycycline, a tetracycline antibiotic, causes photosensitivity in a substantial proportion of users, enough that it shows up clearly in controlled phototesting. Thiazide diuretics like hydrochlorothiazide have been linked to increased skin cancer risk with prolonged use, likely mediated in part through UV sensitization. Fluoroquinolone antibiotics can cause severe phototoxic blistering in some patients.
Hydroxychloroquine does not belong in that category. The phototesting data show no consistent change in UV thresholds, and the documented reactions are confined to scattered case reports rather than cohort-level effects.1PubMed. Sensitivity to UV light during treatment with chloroquine in rheumatoid arthritis If you have taken doxycycline before and remember burning easily, that experience does not predict what will happen on hydroxychloroquine. The drugs work differently and affect the skin differently.
When to Talk to Your Doctor
Certain skin changes while on hydroxychloroquine deserve a phone call, not because they are emergencies, but because they can be mistaken for other things and managed better with early attention:
- Unusual sunburn pattern: Burning at exposure levels that never bothered you before, especially if the redness is sharply limited to sun-exposed skin while covered areas look normal.
- Blue-gray skin patches: Gradual darkening of skin, particularly on the shins, forearms, or face, that does not match a normal tan pattern. This could indicate hydroxychloroquine-induced pigment deposition.
- Worsening lupus rash: If you take hydroxychloroquine for lupus and notice that your photosensitive rashes are getting worse rather than better, the drug may not be controlling your disease adequately, or in rare cases it could be contributing to the problem.
- Vision changes: Not sun-related, but worth mentioning since hydroxychloroquine accumulates in the retina over time. Regular eye exams are part of long-term monitoring for anyone on this drug, and vision changes should be reported promptly.
The case report of a woman developing both skin hyperpigmentation and eye changes after three years underscores that hydroxychloroquine’s side-effect profile is dominated by its tissue-accumulation behavior rather than by acute sun reactions.3Frontiers in Immunology. Hydroxychloroquine-induced hyperpigmentation of the skin and bull’s-eye maculopathy in rheumatic patients: a case report and literature review The long half-life means that effects build gradually and resolve slowly, which makes ongoing monitoring more important than any single sunny afternoon.4PubMed Central. Pharmacology of Chloroquine and Hydroxychloroquine